Amid overwhelming public demand for alternative COVID-19 vaccines, IHH Singapore officially began offering its first batch of 10,000 doses of the Sinopharm COVID-19 vaccine on 30 August.
With this first batch of 10,000 doses offered across Gleneagles Hospital, Mount Elizabeth Hospital and Parkway Shenton clinics in Duxton and One Raffles Quay, IHH Singapore is able to inoculate some 5,000 people.
Dr Noel Yeo, Chief Operating Officer of IHH Healthcare Singapore, said that more than 6,000 individuals had registered their interest to receive the Sinopharm vaccine even before it was made available.
"We were aware there is a demand for alternative vaccines. However, the response for Sinopharm has been overwhelming. We are making plans for second orders but we have to clear approvals from HSA (Health Sciences Authority) first,” he said.
For those looking for alternative vaccines, the Sinopharm vaccine has a reported higher efficacy rate compared to the Sinovac vaccine - 79 per cent compared to 51 per cent - and reportedly milder side effects.
Related Stories
-(1).png?sfvrsn=c64976f_1)
Advancing Care Across Every Stage of the Cancer Journey: Lessons for Life 2026
Mount Elizabeth Hospitals and Parkway Cancer Centre brought clinicians, partners and the community together at Lessons for Life 2026 to reflect on the progress of cancer care and the collective work needed to support patients across every part of their journey.
.png?sfvrsn=c2e0cca7_1)
Premier Integrated Rehab Turns Surplus Uniforms into Sustainable Corporate Gifts
Premier Integrated Rehab transformed 85kg of surplus uniforms into 500 handcrafted items through a purpose-driven upcycling initiative that supports environmental sustainability and community empowerment.
A New Chapter for Mount Elizabeth Hospital
IHH Catalyst Launches in India with First Startup Cohort
10 startups. Four days in Gurgaon. Endless possibilities for better care.
IHH Healthcare Strengthens India Presence with Integrated Platform and Innovation Push
IHH Healthcare is accelerating its expansion in India, as rising healthcare demand drives the Group to scale its operations through integration, capacity growth and innovation-led initiatives.
IHH Healthcare calls for urgent shift from climate awareness to action at Sustainability Week Asia
At the 6th annual Economist Impact Sustainability Week Asia, IHH Healthcare’s Group Chief Sustainability Officer Yasemin Tecmen Stubbe underscored the growing urgency for organisations to embed climate resilience into day-to-day operations, rather than treating it as a future concern.
